146 F.Supp.2d 572 (D.N.J. 2001), Civ.99-2006, Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.
Linked as:
Extract
146 F.Supp.2d 572 (D.N.J. 2001), Civ.99-2006, Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 934 F.Supp. 925 (N.D.Ill. 1995), 95 C 3328, Abbott Laboratories v. Zenith Laboratories, Inc.
- Federal Cases - 10 F.Supp.2d 446 (D.N.J. 1998), Civ. 98-2006, Ben Venue Laboratories, Inc. v. Novartis Pharmaceutical Corp.
- Federal Cases - 110 F.3d 1562 (Fed. Cir. 1997), 96-1466, Glaxo, Inc. v. Novopharm, Ltd.
- Federal Cases - 212 F.3d 1241 (Fed. Cir. 2000), 99-1365, Bayer AG and Bayer v Elan Pharm.
- Federal Cases - 239 F.3d 1297 (Fed. Cir. 2001), 00-1260, Biovail Corp International v. Galephar Inc
